Le Lézard
Classified in: Business
Subject: STR

Canadian Investment Regulatory Organization Trade Resumption - DEC


VANCOUVER, BC, Oct. 19, 2023 /CNW/ - Trading resumes in:

Company: Decade Resources Ltd. 

TSX-Venture Symbol: DEC 

All Issues: Yes

Resumption (ET): 1:00 PM

CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Canadian Investment Regulatory Organization (CIRO) ? Halts/Resumptions


These press releases may also interest you

at 07:15
Rimini Street, Inc. , a global provider of end-to-end enterprise software support, products and services, the leading third-party support provider for Oracle and SAP software, and a Salesforce and AWS partner, today announced results for the fiscal...

at 07:10
Novocure today reported financial results for the quarter ended March 31, 2024. Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer by developing and commercializing its innovative therapy,...

at 07:10
Upbound Group, Inc. (the "Company" or "Upbound") today announced results for the quarter ended March 31, 2024. The earnings release, financial tables and related materials can be found on the Company's investor relations website at...

at 07:10
PENN Entertainment, Inc. ("PENN" or the "Company") today reported financial results for the three months ended March 31, 2024. Jay Snowden, Chief Executive Officer and President, said: "Our property level performance showed resilience this...

at 07:10
Hayward Holdings, Inc. ("Hayward" or the "Company"), a global designer, manufacturer and marketer of a broad portfolio of pool and outdoor living technology, today announced financial results for the first quarter ended March 30, 2024 of its fiscal...

at 07:10
Bicycle Therapeutics plc , a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today reported recent business progress and financial results for the...



News published on and distributed by: